Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome

Thorax

Volumn 54, Issue 9, 1999, Pages 771-778

  Schnabel, Armin ^a   Csernok, Elena ^a   Braun, Jörg ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bronchoalveolar lavage; Churg Strauss syndrome; Eosinophils; Neutrophils

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE; PEROXIDASE;

ADULT; ARTICLE; CELL ACTIVATION; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LOWER RESPIRATORY TRACT; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; REMISSION; STAGING; WEGENER GRANULOMATOSIS;

EID: 0032771304     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.9.771     Document Type: Article

References (35)

1. 1 Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical aproach to the Churg-Strauss syndrome. Medicine 1984;63:65-81.
2. 2 Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37.
3. 3 Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
4. 4 Churg J. Churg-Strauss syndrome. In: Thurlbeck WM, Churg AM, eds. Pathology of the lung. Stuttgart, New York: Thieme, 1995:425-35.
5. 5 Tatsis E, Schnabel A, Gross WL. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998;129:370-4.
6. 6 Olivieri D, Pesci A, Bertorelli G. Eosinophilic alveolitis in immunologic interstitial lung disorders. Lung 1990;Suppl: 964-73.
7. 7 Wallaert B, Gosset P, Prin L, et al. Bronchoalveolar lavage in allergic granulomatosis and angiitis. Eur Respir J 1993;6: 413-7.
8. 8 Schmidt B, Teschler H, Kroegel C. Bronchoalveolar lavage cell profiles in Wegener's granulomatosis, chronic eosinophilic pneumonia and Churg-Strauss syndrome. Eur Respir J 1989;2(Suppl 8):641S.
9. 9 Rothenberg ME. Eosinophilia. N Engl J Med 1998;338: 1592-600.
10. 10 Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 1998;13(Suppl 1):16-20.
11. 11 Travis WD, Hoffman GS, Leavitt RY, et al. Surgical pathology of the lung in Wegener's granulomatosis. Am J Pathol 1991;15:315-33.
12. 12 Brouwer E, Huiterna M, Mulder AHL, et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994;45:1120-31.
13. 13 Mrowka C, Csernok E, Gross WL, et al. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis. Am J Kidney Dis 1995;25:253-61.
14. 14 Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
15. 15 Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitis. Proposal of an International Consensus Conference. Arthritis Rheum 1994;37:187-92.
16. 16 Nölle B, Specks U, Lüdemann J, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
17. 17 Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33: 1101-7.
18. 18 Segelmark M, Persson B, Hellmark T, et al. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 1997;108:167-74.
19. 10 Schnabel A, Holl-Ullrich K, Dalhoff K, et al. Efficacy of transbronchial biopsy in pulmonary vasculitides. Eur Respir J 1997;10:2738-43.
20. 20 Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive disease. J Allergy Clin Immunol 1993;92:537-48.
21. 21 Chanez P, Enander I, Jones I, et al. Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int Arch Allergy Immunol 1996;111:83-8.
22. 22 Tai P, Holt ME, Denny P, et al. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. BWJ 1984; 289:400-2.
23. 23 Schmitt WH, Csernok E, Kobayashi S, et al. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998;41:445-52.
24. 24 Bousquet J, Chanez P, Lacoste JY, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
25. 25 Hällgren R, Bjermer R, Lundgren R, et al. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139:373-7.
26. 26 Shijubo N, Shigehara K, Hirasawa M, et al. Eosinophilic cationic protein in chronic eosinophilic pneumonia and eosinophilic granuloma. Chest 1994;106:1481-6.
27. 27 Borregaard N, Cowland JB, Granules of the human polymorphonuclear leukocyte. Blood 1997;10:3503-21.
28. 28 Schmekel B, Karlsson SE, Linden M, et al. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990;14:447-54.
29. 29 Braun J, Dalhoff K, Lipp R, et al. Myeloperoxidase, Lactoferrin und Elastase in bronchoalveolärer Lavage und Plasma bei Pneumonie. Pneumologic 1992;46:141-7.
30. 30 Riise G, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995;50:360-5.
31. 31 Pohl WR, Schenk E, Umek H, et al. Aussagekraft der Sekretionsprodukte von Eosinophilen und Neutrophilen in der bronchoalveolären Lavage bei Patienten mit idiopathischer Lungenfibrose. Wein Klin Wochenschr 1993;105:387-92.
32. 32 Cailes JB, O'Connor C, Pantelidis P, et al. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Eur Respir J 1996;9:992-9.
33. 33 Cantin AM, North SL, Fells GA, et al. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987;79:1665-73.
34. 34 Hoffman GS, Sechler JMG, Gallin JI, et al. Bronchoalveolar lavage analysis in Wegener's granulomatosis. Am Rev Respir Dis 1991;143:401-7.
35. 35 Schnabel A, Reuter M, Gloeckner K, et al. Bronchoalveolar lavage cell profiles in Wegener's granulomatosis. Respir Med 1999 (in press).